Elrig Drug Discovery 2024 - International Biopharmaceutical Industry

Current Edition

Issue 9, Volume 3

Current Features

Issue 9, Volume 3

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Elrig Drug Discovery 2024

We are delighted to be supporting ELRIG at this year’s Drug Discovery 2024 Conference.

🌟 Registration is now open! Don’t Miss Out! 🌟

🚀 This fantastic event will be hosted at ExCeL, London on October 2-3. Join industry leaders and innovators for a dynamic experience that fuels your drive for discovery. Featuring a lineup of 100+ speakers, 2000 delegates, 200 exhibitors, and 260 enlightening posters. Don’t miss this (free-to attend) opportunity to connect, learn, and innovate!

Scientific Tracks will cover:

Therapeutic themes like ageing mechanisms and cell & gene therapy
Practical aspects of drug discovery including assay design, high-content imaging, and target identification
The Tech Theatre will discuss covering sustainability in drug discovery, and robotics, automation, and AI
Content from our Scientific Content Partners: Cell & Gene Therapy Catapult, Royal Society of Chemistry, SBi2, and SLAS, offering science tracks prepared by their community members.